Eli Lilly to allow more patients to apply for special access to unapproved obesity drug

Momentum

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Who reported it (11)

• 
  Eli Lilly will offer experimental obesity drug early to some patients. Who qualifies? Houston Chronicle · 49d ago
• 
  Retatrutide access expands, putting physicians on the front line of ‘next-gen’ GLP-1 demand MDLinx · 49d ago
• 
  Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more STAT · 49d ago broke it first
• 
  Recon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca RAPS · 49d ago
• 
  Eli Lilly is allowing more patients early access to its experimental weight loss drug qz.com · 49d ago
• 
  Three biotechs with three news updates STAT · 49d ago broke it first
• 
  This Next-Gen GLP-1 Is Blowing Up the Black Market Economy Marie Claire · 49d ago
• 
  Retta Weight Loss: The Evidence, Benefits, and Realistic Expectations FC Bayern · 49d ago
• 
  Spotlight On: Good news and bad news for Lilly's triple agonist FirstWord Pharma · 49d ago
• 
  Eli Lilly to offer early access to next-gen obesity drug to some patients Reuters · 49d ago
• 
  Eli Lilly to allow more patients to apply for special access to unapproved obesity drug STAT · 49d ago broke it first

Related trends